[ad_1] Pfizer’s (PFE) interest in Seagen (SGEN) marks the second time in a year the cancer-focused biotech has been an…
Read More »Merck
[ad_1] Moderna stock fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as fourth-quarter earnings…
Read More »
[ad_1] <img class="img-responsive" src="https://cdn.benzinga.com/files/imagecache/1024x768xUP/images/story/2022/12/21/ngm_logo_light__58a0e6464f7ef4d049702f4c4705e5b5.png"><ul> <li>Merck Co Inc (NYSE:<a class="ticker" href="https://markets.businessinsider.com/stocks/mrk-stock">MRK</a>) has notified NGM Biopharmaceuticals… [ad_2] Share this news on your Fb,Twitter and Whatsapp…
Read More »
[ad_1] Moderna was rising Monday after an analyst at Jefferies upgraded the stock citing confidence in the vaccine maker’s growth…
Read More »
[ad_1] Moderna stock jumped by double digits Tuesday on positive news about the company’s cancer vaccine, but Chardan Capital Markets…
Read More »
[ad_1] Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form…
Read More »
[ad_1] Breadcrumb Trail Links PMN Business Author of the article: Reuters Julie Steenhuysen and Michael Erman Publishing date: Dec 13,…
Read More »
[ad_1] McCormick PulteGroup and Merck Merck were among the large U.S. companies that declared dividend increases this week. McCormick (ticker:MKC)…
Read More »
[ad_1] Sometimes, a single worry grows so large that it obscures all the good things happening at the same time.…
Read More »
[ad_1] A week after announcing its acquisition of Imago Biosciences (IMGO), things are looking up for pharmaceutical concern Merck & Co…
Read More »